Peptide dendrimers G3KL and TNS18 inhibit Pseudomonas aeruginosa biofilms

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Multidrug-resistant bacteria pose a significant threat to public health.
• Peptide dendrimers have emerged as potential antimicrobial agents.
• Controlling biofilm formation is crucial for combating persistent infections.

Purpose of the Study:

• To investigate the efficacy of peptide dendrimers G3KL and TNS18 against Pseudomonas aeruginosa.
• To determine the effect of these peptide dendrimers on biofilm formation and bacterial motility.
• To elucidate the mechanism of action of these peptide dendrimers.

Main Methods:

• Minimum inhibitory concentration (MIC) determination.
• Biofilm inhibition and eradication assays.
• Scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM).
• Membrane potential analysis.
• RNA sequencing (RNA-seq).

Main Results:

• Peptide dendrimers G3KL and TNS18 strongly inhibited biofilm formation and swarming motility of P. aeruginosa PA14 below their MIC.
• Higher concentrations were required for the eradication of preformed biofilms.
• Peptide dendrimers dose-dependently destroyed biofilm structure and thickness, leading to complete dispersion.
• Membrane potential analysis suggested the cytoplasmic membrane as a target, similar to polymyxin B.
• RNA-seq revealed differential effects on the arnBCADTEF operon, indicating distinct membrane targeting mechanisms.

Conclusions:

• Peptide dendrimers G3KL and TNS18 exhibit potent activity against planktonic and biofilm forms of P. aeruginosa.
• These peptide dendrimers are promising candidates for clinical development in treating bacterial infections.
• The compounds target bacterial cell membranes through distinct mechanisms.